Satoshi Hori

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Linzagolix, with and without add-back therapy, in women with endometriosis-associated pain: results from EDELWEISS 6, a double-blind randomized extension and withdrawal study.

Linzagolix, with and without add-back therapy, in women with endometriosis-associated pain: results from EDELWEISS 6, a double-blind randomized extension and withdrawal study.

Journal: Human reproduction open
Published: September 22, 2025

Linzagolix with and without hormonal add-back therapy for symptomatic uterine fibroids: PRIMROSE 1 & 2 long-term extension and withdrawal study.

Linzagolix with and without hormonal add-back therapy for symptomatic uterine fibroids: PRIMROSE 1 & 2 long-term extension and withdrawal study.

Journal: Fertility and sterility
Published: February 13, 2025

Pain Reduction in Linzagolix-Treated Patients With Uterine Fibroids: A Secondary Mediation Analysis of the PRIMROSE 1 and 2 Phase 3 Trials.

Pain Reduction in Linzagolix-Treated Patients With Uterine Fibroids: A Secondary Mediation Analysis of the PRIMROSE 1 and 2 Phase 3 Trials.

Journal: BJOG : an international journal of obstetrics and gynaecology
Published: December 24, 2024

Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials.

Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials.

Journal: Human reproduction open
Published: December 20, 2024

Linzagolix rapidly reduces heavy menstrual bleeding in women with uterine fibroids: an analysis of the PRIMROSE 1 and 2 trials.

Linzagolix rapidly reduces heavy menstrual bleeding in women with uterine fibroids: an analysis of the PRIMROSE 1 and 2 trials.

Journal: Fertility and sterility
Published: September 20, 2024

Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management.

Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management.

Journal: Hematological oncology
Published: September 01, 2021

Resolving the immune landscape of human prostate at a single-cell level in health and cancer.

Resolving the immune landscape of human prostate at a single-cell level in health and cancer.

Journal: Cell reports
Published: January 25, 2021

The provision of prostate cancer patient information leaflets on an electronic tablet: A further step to paperless health-care provision.

The provision of prostate cancer patient information leaflets on an electronic tablet: A further step to paperless health-care provision.

Journal: Urology annals
Published: October 30, 2020

Impact of Interethnic Difference of Collateral Angioarchitectures on Prevalence of Hemorrhagic Stroke in Moyamoya Disease.

Impact of Interethnic Difference of Collateral Angioarchitectures on Prevalence of Hemorrhagic Stroke in Moyamoya Disease.

Journal: Neurosurgery
Published: September 21, 2017

Longitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset.

Longitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset.

Journal: Journal of neurosurgery
Published: September 06, 2017

Loss of hSef promotes metastasis through upregulation of EMT in prostate cancer.

Loss of hSef promotes metastasis through upregulation of EMT in prostate cancer.

Journal: International journal of cancer
Published: March 09, 2016

Intradural anterior transpetrosal approach.

Intradural anterior transpetrosal approach.

Journal: Neurosurgical review
Published: January 28, 2016
Showing 1-12 of 24

Last Updated: 09/26/2026